Prosight Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-670,300
| Closed | -$449K | – | 36 |
|
2022
Q1 | $449K | Sell |
670,300
-131,880
| -16% | -$88.3K | 0.29% | 28 |
|
2021
Q4 | $1.04M | Buy |
802,180
+308,972
| +63% | +$399K | 0.62% | 26 |
|
2021
Q3 | $1.07M | Buy |
493,208
+237,093
| +93% | +$514K | 0.59% | 33 |
|
2021
Q2 | $699K | Buy |
256,115
+50,215
| +24% | +$137K | 0.44% | 35 |
|
2021
Q1 | $537K | Buy |
+205,900
| New | +$537K | 0.44% | 32 |
|